West, N., Hemmings, G., Richman, S., Taylor, M., Chambers, P., Magill, L., . . . Quirke, P. (2012). KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial.
Chicago Style (17th ed.) CitationWest, N., et al. KRAS and BRAF Mutational Status Can Be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT Trial. 2012.
MLA (9th ed.) CitationWest, N., et al. KRAS and BRAF Mutational Status Can Be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT Trial. 2012.